Appointment of Chief Executive Office and Issue of Equity
LONDON, UK / ACCESSWIRE / February 3, 2021 / World High Life Plc: Appointment of Chief Executive Officer World High...
News
Netsmart Acquires GPM to Enhance Provider Digitization and Mobile Workflows
OVERLAND PARK, Kan.--(BUSINESS WIRE)--Today, Netsmart announced the acquisition of GPM, a North Carolina-based Software-as-a-Service technology and services company, dedicated to...
Imcyse Announces Start of Phase 1b/2a IMPACT Study in Patients with Recent Onset Type 1 Diabetes
LIEGE, BELGIUM / ACCESSWIRE / February 3, 2021 / Imcyse, a clinical-stage biopharmaceutical company pioneering the development of a new...
Jaguar Health’s Chief of Sustainable Supply, Dr. Steven King, an Ethnobotanist, to Discuss Crofelemer Development on February 4th at 2 PM Eastern as Part of the American Botanical Council’s Sustainable Herbs Program Webinar Series
Webinar Title: The Development of Crofelemer: Connecting Ethnobotany, Conservation, Biocultural Diversity, Indigenous Knowledge and Global Public Health Webinar registration link...
Jupiter Wellness Appoints Ryan T. Allison as VP of Business Development
Tech Specialist With Track Record of Applying Big Data and Technology Infrastructure To Drive Rapid Revenue Growth JUPITER, FL /...
The Smilo App, an App That Gives Users an Instant Oral Health Rating, is Officially Launched
For People Who are Reluctant to Visit Their Dentist, the Smilo App Will Help Put them in Charge of their...
9 Meters Biopharma, Inc. highlighted at upcoming Truist Securities’ CEO Strategic Vision Conference Call Series
RALEIGH, NC / ACCESSWIRE / February 3, 2021 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage rare and unmet needs-focused...
Avinger Tigereye CTO Crossing Featured in Live Case at LINC 2021
REDWOOD CITY, CA / ACCESSWIRE / February 3, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the...
Imcyse Enters into Research Collaboration and License Agreement for its Imotope(TM) Technology with Pfizer in Rheumatoid Arthritis
Imcyse and Pfizer to collaborate to develop ImotopeTM candidates to potentially treat Rheumatoid Arthritis Pfizer to lead clinical development and...
Sonnet BioTherapeutics Announces Abstract Accepted for Presentation at AACR 2021 Annual Meeting
PRINCETON, NJ / ACCESSWIRE / February 3, 2021 / Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a clinical-stage company developing targeted immunotherapeutic...
Planet 13 Begins Construction of Orange County SuperStore
LAS VEGAS, NV / ACCESSWIRE / February 3, 2020 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQB:PLNHF) ("Planet 13" or the "Company"),...
OPKO Health to Report Fourth Quarter 2020 Financial Results on February 18, 2021
MIAMI, Feb. 03, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for...
Alliance for Regenerative Medicine Responds to EU Beating Cancer Plan
Alliance for Regenerative Medicine Responds to EU Beating Cancer Plan ATMPs are uniquely positioned to attack cancer at its source,...
REPEAT – Pure Extracts Announces Submission for Class 1 Natural Product Number (NPN)
VANCOUVER, British Columbia, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure...
Generex Biotechnology Announces Call-in Details and Agenda for Shareholder Conference Call on Friday February 5, 2021 at 9:00 AM
The access information for the investor conference call is as follows: Domestic US/Canada - 1-(866) 342-8588Direct Toll / International -...
Health Professional Resources Launches High-Performance Personal Protective Equipment (PPE) Line in Strategic Partnership with MAS Holdings
U.S.-based health care wholesaler backed by leading global manufacturer behind Nike to bring essential PPE supplies to small and mid-sized...
Marrone Bio Innovations Issues Shareholder Letter
DAVIS, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“Marrone Bio”), an international leader in...
PDS Biotech Announces Preliminary Efficacy Achievement in Phase 2 Combination Trial of PDS0101 Led by the National Cancer Institute
Full enrollment triggered by observation of 3 objective responses in continued evaluation of the initial group of 8 patientsFLORHAM PARK,...
AXIM® Biotechnologies Begins Clinical Trials on Its ImmunoPass Rapid Diagnostic Test With Vaccine Recipients
SAN DIEGO, Feb. 03, 2021 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an...
Telo Genomics Retains Former Abbott & Siemens Veteran Gregg Mayer to Lead the Development of the Company’s Industry Partnership Strategy
TORONTO, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Telo Genomics Corp. (TSX-V: TELO) (the “Company” or “TELO”) is pleased to announce...